Home
Home

Alzheimer's disease

Novartis Ramps Up Alzheimer’s Drug Pursuit as Rivals Fail

Novartis Ramps Up Alzheimer’s Drug Pursuit as Rivals Fail
Bloomberg

Failure Of Baxter's Trial Another Blow To Alzheimer's Treatment

Failure Of Baxter's Trial Another Blow To Alzheimer's Treatment
Forbes

NeuroPhage banks $6.4M for Alzheimer's drug development effort

NeuroPhage banks $6.4M for Alzheimer's drug development effort
Fierce Biotech

Biotech startup hustles new Alzheimer's program to the clinic

Biotech startup hustles new Alzheimer's program to the clinic
Fierce Biotech

Eli Lilly Sues J&J for Patents Rights in Alzheimer Drug Race

Eli Lilly Sues J&J for Patents Rights in Alzheimer Drug Race
Bloomberg

Lilly And Sanofi CEOs Take Two Very Different R&D Paths In Alzheimer's Disease

Lilly And Sanofi CEOs Take Two Very Different R&D Paths In Alzheimer's Disease
Forbes

Marking the Way for Alzheimer's Drugs

Marking the Way for Alzheimer's Drugs
Motley Fool

Lilly to acquire Alzheimer's imaging agents from Siemens

Lilly to acquire Alzheimer's imaging agents from Siemens
Reuters

Amarantus LymPro Could Be A Game-Changer For Alzheimer's Diagnosis

Amarantus LymPro Could Be A Game-Changer For Alzheimer's Diagnosis
Seeking Alpha

Dismay at Sanofi stance on Alzheimer's research

Dismay at Sanofi stance on Alzheimer's research
Pharma Times, UK